Luo Ying
Gyre Therapeutics, Inc. · Chief Executive Officer
Luo Ying is listed in filings as Chief Executive Officer at Gyre Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 7, 2026, including sale activity. Recent filings connect the profile to Gyre Therapeutics, Inc. (GYRE). The current snapshot covers public activity from Aug 16, 2024 to May 7, 2026. Reported amounts are shown as $81.5K to $259.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $1.4k179 shares | SellMay 5, 2026 | $8.01 | $5.74 |